tilavonemab (ABBV-8E12) - AbbVie
https://alz.confex.com/alz/2024/meetingapp.cgi/Paper/90930
 
Indira Ruth Garcia Cordero, PhD1; Mohsen Hadian, PhD1; Ece Bayram, MD PhD2; Federico Rodriguez-Porcel, MD3; Christopher Stephen4; Alex Pantelyat, MD5; Jay Iyer6; Tao Xie7; Adam L Boxer, MD, PhD8; Douglas Gunzler9; Marian Dale10; Nikolaus McFarland11; Kyurim Kang12; Matthew Swan13; Anne-Marie Wills, MPH, MD14; Anthony E Lang, MD, FRCPC15,16; Maria Carmela Tartaglia, MD15,16,17
 
Jun 20, 2024
 
Prev Next